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One laboratory-based and two non-laboratory-based models with and without blood pressure measures are developed based on
data of 14815 men and 16617 women aged 25–64 years. During the followup 1134 men and 566 women developed coronary heart
disease (CHD). The area under the receiver operating characteristic curve (95% CI) for prediction of CHD incidence was 0.823
(0.807–0.839) for the laboratory-based model, 0.808 (0.791–0.824) and 0.803 (0.787–0.820) for the non-laboratory-based models
with and without systolic blood pressure in men (P<0.01 for overall comparison), and 0.878 (0.856–0.901), 0.871 (0.848–0.894),
and 0.864 (0.840–0.887), respectively, in women (P<0.01). The predicted rates matched well with the observed ones (P>0.10).
Compared with the model without blood pressure, the non-laboratory-based model with blood pressure tended to reclassify
individuals into the higher risk categories for both event and nonevent groups in both genders. The study concludes the predictive
property of the non-laboratory-based models are good.
1.Introduction
Beginning50yearsago,theFraminghamHeartStudyforever
changed our approach to predict and prevent coronary heart
diseases by identifying major risk factors for myocardial
infarction (MI) [1–4] and developing risk assessment func-
tion based on the major risk factors [5, 6]. Since then
many other cardiovascular diseases (CVDs) risk prediction
functions or scores have been developed [7–12]. All these
previous prediction models require laboratory and clinical
examinations and target at high-risk individuals who visit a
clinic. A simpliﬁed risk assessment tool is, however, required
for CVD prevention through population approach that aims
to reduce the risk factors at population levels through
lifestyle and environment changes. Such a simpliﬁed tool is
also useful in less developed countries where the health care
resources are limited but the largest increase in CVD will
occur[13].Recently,anAmericanstudyshowedthatamodel
that uses non-laboratory-based risk factors predicted CVD
events as accurately as one that relied on laboratory-based
values [14]. This has, however, not been conﬁrmed yet by
other studies. Based on data of the National FINRISK Study,
we developed a model which does not include laboratory
variables and blood pressure measurement and compared
it to the models which includes these measurements with
regard to their predictive ability of ﬁrst events of coronary
heart disease (CHD).
2. Methods
The National FINRISK Study has been carried out every
5th year since 1972 to monitor CVD risk factor levels and
evaluate health strategies to lower CVD events in Finland
[15] based on random population representative samples.
Cohorts ﬁrst examined in 1982, 1987, 1992, 1997, and 2002,
including about 14815 Finnish men and 16617 Finnish
women aged 24–64 years, were followed up using national
registers until 31 December of 2007. The maximum follow-
up length was 5.9 years for the 2002 cohort and 25.9 years2 International Journal of Vascular Medicine
Table 1: Baseline characteristics of study cohorts by survey years.
Cohort
1982 1987 1992 1997 2002
No of participants (Men%) 8036 (48.8) 4720 (48.0) 5298 (46.7) 6437 (47.0) 6941 (45.0)
Age, year 43 (11.1) 42 (11.1) 43 (11.3) 44 (11.3) 44 (11.5)
Body mass index, kg/m2 25.9 (4.2) 26.1 (4.3) 26.0 (4.4) 26.3 (4.5) 26.6 (4.6)
Systolic blood pressure, mmHg 140 (19.6) 138 (19.2) 135 (19.2) 133 (18.5) 133 (18.7)
Diastolic blood pressure, mmHg, 84 (12.1) 84 (11.6) 81 (12.0) 82 (11.3) 78 (11.5)
HDL-cholesterol, mmol/L 1.31 (1.29) 1.41 (1.29) 1.36 (1.28) 1.37 (1.30) 1.46 (1.31)
Total cholesterol, mmol/L 5.92 (1.23) 5.81 (1.23) 5.50 (1.22) 5.38 (1.21) 5.44 (1.21)
Years of education 9.4 (3.6) 10.3 (3.7) 11.4 (3.8) 12.0 (3.8) 12.8 (3.7)
Current smoker, % 28.8 26.7 28.0 25.4 28.1
History of hypertension, % 12.0 12.4 13.2 15.8 16.1
History of diabetes, % 1.3 1.5 1.6 2.2 2.2
Parent(s) with myocardial infarction, % 29.1 30.3 23.1 21.3 21.4
Incapable of walking 500 meters, % 2.4 1.9 2.1 0.8 1.1
Maximum follow-up years 26.0 21.0 16.0 10.9 6.0
No. of CHD events (%) 945 (11.8) 349 (7.4) 205 (3.9) 141 (2.2) 52 (0.7)
Data are mean (SD) or as noted.
for the 1982 cohort. The survey methods followed the stand-
ard protocol (http://www.ktl.ﬁ/ehrm) ,w h i c hh a v eb e e nd e -
scribed in details elsewhere [15].
2.1. Ascertainment of the CHD Events. First ever CHD events
were ascertained through computerized record linkage of
the unique national ID numbers of the survey participants
to the national Causes of Death Registry and the national
Hospital Discharge Registry. International Classiﬁcation of
Disease (ICD), 9th revision (10th revision), was used for
the classiﬁcation of either the fatal or the nonfatal events.
ICD codes of 410–414 (I20–I25) for fatal CHD and 410-411
(I21-I22, I24) for nonfatal acute MI were applied. The ﬁrst
nonfatal MI and the ﬁrst fatal CHD events constitute the
incident CHD events. Subjects with a self-reported history
of ischemic heart diseases or ascertained from the registers as
having ischemic heart diseases before the baseline survey of
each study cohort were excluded from the data analysis.
2.2. Statistical Analysis. Cox proportional hazard model
analyses were performed to relate factors to the ﬁrst ever
CHD events using STATA 11.0. The assumption of the
proportionality was tested based on Schoenfeld residuals
(phtest) method for each explanatory variable for each
cohort and for men and for women. The results showed the
assumption of the proportionality of hazards holds; P values
of the global tests varied from 0.20 to 0.93.
2.2.1. Selection of Risk Predictors. 50 candidate variables,
including age, marital status, spouse and children, self-
evaluation of one’ personal or family life, education and
occupation, stress from work and family, family income,
dietary components, physical activities at work and leisure
time, tobacco and alcohol consumption, self-consideration
of one’s health status and functional capacity, history
of diabetes or hypertension or elevated total cholesterol,
parents’ history of cardiovascular diseases, body mass index
(BMI), and laboratory measurements of total cholesterol
and HDL-cholesterol, ratio of total cholesterol to HDL
cholesterol (cho/HDL), were examined in either univariable
orstepwisemultivariablemodels.Avariablelistwithdetailed
variable description is presented in the supplemental digital
Table 1 in supplementary material available online at doi:
11.55/2011/823782. Age, residential areas, survey years, and
years of education were ﬁtted in all models. Cohort speciﬁc
baseline survival function (or rate) at the mean values of
risk factors of the whole study population was estimated. All
the continuous variables were logarithmically transferred to
improve discrimination and calibration of the models and to
minimize the inﬂuence of extreme observations.
2.2.2. Three Prediction Models and CHD Risk Assessment
Function. ThreediﬀerentCoxmodelswereﬁnallyconstruct-
ed: one laboratory based and two non laboratory based.
Both the chol/HDL and the systolic blood pressure entered
into the laboratory based model. BMI did not enter into
the laboratory based model, but into the non-laboratory-
based models at the absence of the chol/HDL. Chol/HDL
was removed from the laboratory-based model to form the
non-laboratory-based models, and systolic blood pressure
was further taken out from the non-laboratory-based model
to form the layperson-oriented models.
The regression coeﬃcient of each factor was estimated
based on pooled data of all ﬁve cohorts, but the cohort-
speciﬁc baseline survival rates at 10 years derived from the
Cox models were used to calculate the 10-year absolute
risk for each cohort using the formula described in the
Framingham Heart Study [16].International Journal of Vascular Medicine 3
Table 2: Baseline characteristics of participants according to incidence of coronary heart disease (CHD) at the end of followup.
Men Women
Not CHD CHD Not CHD CHD
No. of participants (%) 13684 (92.4) 1131 (7.6) 16056 (96.6) 561 (3.4)
Age, year 43 (11.1) 51 (9.0) 43 (11.3) 55 (8.0)
Body mass index, kg/m2 26.5 (3.8) 27.7 (4.0) 25.7 (4.8) 28.7 (5.3)
Systolic blood pressure, mmHg 138 (17.4) 149 (19.1) 132 (19.7) 153 (22.4)
Diastolic blood pressure, mmHg, 84 (11.8) 90 (11.7) 79 (11.3) 87 (11.5)
HDL-cholesterol, mmol/L 1.25 (1.28) 1.15 (1.31) 1.52 (1.22) 1.36 (1.28)
Total cholesterol, mmol/L 5.65 (1.22) 6.39 (1.20) 5.50 (1.22) 6.57 (1.21)
Current smoker, % 35.0 43.9 20.2 20.5
History of hypertension, % 13.4 23.3 12.9 37.1
History of diabetes, % 1.8 5.5 1.3 7.1
Parent(s) with myocardial infarction, % 23.8 28.5 25.4 34.0
Incapable of walking 500 meters, % 1.3 5.1 1.5 8.0
Years of education in tertiles, %
Low 30.8 36.5 31.0 34.6
Middle 33.4 36.2 32.9 35.8
High 35.8 27.3 36.1 29.6
Data are mean (SD) or percentage.
2.2.3. Assessment of the Model Performance and
Comparison between Models
Discrimination. Receiver operating characteristic (ROC)
curves of the 10-years absolute CHD risk calculated based on
the estimates of the three diﬀerent Cox models were plotted.
Areas under the curves (AUCs) were calculated to evaluate
discrimination of the models, and the diﬀerences in AUCs
were tested based on C statistic.
Calibration. Calibration, a measure of agreement between
observed and predicted CHD events within 10 years, was
made for the layperson-oriented model. The 10-year abso-
lute CHD risk was used to divide individuals into deciles of
the predicted risk. The mean of the predicted probability of
having the CHD in each decile and the observed probability
obtained using Kaplan-Meier method was plotted. The
diﬀerence between observed and predicted rate was tested
using χ2-test with 9df.
The Net Reclassiﬁcation Improvement (NRI). NRI was cal-
culated according to Pencina et al. [17] to quantify the im-
provement in the right reclassiﬁcation of the layperson-ori-
ented model against the other two models in either event
or non-event groups. According to the guidelines for CVD
prevention from diﬀerent major organizations or study
groups based on 10-year absolute risk assessment [18–20],
10-year CHD risk categories of <5%, 5%–9%, 10%–19%,
and ≥20% were made. If a model moves a CHD event from
a low risk category to a high one, the reclassiﬁcation was
considered right and the mode prediction was improved
compared with the reference model. A downgrade for the
non-events was considered as right reclassiﬁcation.
3. Results
Characteristics of the cohorts are shown in Table 1.B M I
and the prevalence of diabetes have increased while blood
pressureandunfavourablelipidproﬁlesdecreasedduringthe
last 35 years in Finland as reported [15].
Altogether1131(7.6%)ﬁrsteverCHDeventsinmenand
561 (3.4%) in women were observed during the followup.
Individuals who developed CHD events were older and had
higher BMI, blood pressure and worse lipid proﬁles than
those who were free of CHD at the end of the followup
(Table 2). The proportion of people with prior history of
diabetes or hypertension, parent(s) suﬀering from MI, and
self-perceivedworsehealthconditionswerealsohigherinthe
former than in the latter. Current smoking in men and lower
education level in both genders were related to incidence of
CHD.
Theregressioncoeﬃcientsofthepredictorsandthebase-
line survival function for each cohort are shown in Table 3.
The estimated 10-year mean absolute CHD risk were 3.76%,
3.85%, and 3.76% in men for the laboratory based model,
the non-laboratory based models with and without blood
pressure; they was 1.25%, 1.37%, and 1.33%, respectively,
in women. Given a positive test at the risk of ≥20%, the
positive predictive values for 10-years CHD incidence were
similar between the models (22.4% in men and 25.0%
in women by the layperson-oriented model, 20.2% and
25.6% by the laboratory-based model and 21.2% and 21.8%
by the non-laboratory-based model with systolic blood
pressure). However, the number of individuals referred to
further tests or intervention was largest for the laboratory-
based model (n=286) than for the non-laboratory based
models with (n=258) and without (n=209) blood pressure
measurement.4 International Journal of Vascular Medicine
Table 3: Regression coeﬃcients (β) and hazard ratio (HR) for incident coronary heart disease estimated based on diﬀerent Cox models.
Men (n = 14815) Women (n = 16617)
β HR (95% CI) β HR (95% CI)
Laboratory based
Age∗, year 3.893 49.07 (35.25–68.32) 4.972 144.38 (78.41–265.82)
Current smoking 0.579 1.78 (1.58–2.01) 0.930 2.53 (2.04–3.15)
History of diabetes 0.950 2.59 (1.99–3.36) 1.185 3.271 (2.33–4.59)
History of hypertension 0.207 1.23 (1.06–1.42) 0.536 1.71 (1.41–2.06)
Incapable of walking 500 meters 0.429 1.54 (1.17–2.01) 0.586 1.80 (1.32–2.45)
Parent(s) with myocardial infarction 0.223 1.25 (1.10–1.42) 0.438 1.55 (1.30–1.85)
Systolic blood pressure∗, mmHg 1.491 4.44 (2.74–7.21) 1.933 6.91 (3.66–13.05)
Cholesterol to HDL-C ratio∗ 1.078 2.94 (2.43–3.55) 0.998 2.71 (2.08–3.54)
Baseline survival function at 10 years
Cohort 1982 0.978 0.997
Cohort 1987 0.979 0.996
Cohort 1992 0.981 0.997
Cohort 1997–2002 0.984 0.996
Non-laboratory based
Age∗, year 4.012 55.23 (39.76–76.73) 5.256 191.79 (104.26–352.80)
Current smoking 0.630 1.88 (1.66–2.12) 0.956 2.60 (2.10–3.23)
History of diabetes 0.952 2.59 (1.99–3.36) 1.282 3.60 (2.59–5.02)
History of hypertension 0.219 1.24 (1.07–1.44) 0.575 1.78 (1.47–2.14)
Incapable of walking 500 meters 0.480 1.62 (1.23–2.12) 0.539 1.71 (1.25–2.35)
Parent(s) with myocardial infarction 0.258 1.29 (1.13–1.47) 0.402 1.49 (1.25–1.78)
Systolic blood pressure∗, mmHg 1.436 4.20 (2.59–6.84) 1.919 6.81 (3.61–12.87)
Body mass index, kg/m2 0.951 2.59 (1.65–4.05) 0.732 2.08 (1.26–3.44)
Baseline survival function at 10 years
Cohort 1982 0.974 0.996
Cohort 1987 0.977 0.995
Cohort 1992 0.980 0.997
Cohort 1997–2002 0.984 0.996
Layperson oriented
Age∗, year 4.219 68.00 (49.20–93.98) 5.739 310.77 (172.55–559.70)
Current smoking 0.642 1.90 (1.68–2.14) 0.929 2.53 (2.04–3.14)
History of diabetes 0.937 2.55 (1.96–3.31) 1.296 3.65 (2.62–5.10)
History of hypertension 0.303 1.35 (1.17–1.57) 0.722 2.06 (1.71–2.47)
Incapable of walking 500 meters 0.462 1.59 (1.21–2.08) 0.491 1.63 (1.19–2.24)
Parent(s) with myocardial infarction, 0.266 1.30 (1.14–1.49) 0.386 1.47 (1.23–1.75)
Body mass index, kg/m2 1.147 3.15 (2.02–4.91) 0.887 2.43 (1.47–4.02)
Baseline survival function at 10 years
Cohort 1982 0.973 0.996
Cohort 1987 0.977 0.995
Cohort 1992 0.980 0.997
Cohort 1997-2002 0.985 0.996
∗Natural logarithm of the continuous variables.
All three predictive models adequately discriminated
people with CHD events from those without as shown in
Figure 1 (the ROC curves). The AUC (95% CI) was 0.823
(0.807–0.839) for the laboratory-based model, 0.808 (0.791–
0.824) and 0.803 (0.787–0.820) for the non-laboratory-
based models with and without systolic blood pressure in
men, and 0.878 (0.856–0.901), 0.871 (0.848–0.894), and
0.864 (0.840–0.887), respectively, in women. The layperson-
oriented model gave slightly smaller AUC than others
(P<0.001 for overall comparisons in both genders).
Calibration of the layperson-oriented model showed
that the predicted 10-year event rate matched well withInternational Journal of Vascular Medicine 5
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Figure 1: Receiver operating characteristic curves for 10-year incidence of coronary heart disease predicted by the laboratory-based model
(dashed), non-laboratory-based model (solid) and the layperson-oriented model (round dot).
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Figure 2: Observed (Kaplan-Meier, white) and predicted (black) probability of coronary heart disease in 10 years in deciles of risk estimated
by the layperson-oriented model.
the observed event rate across deciles of the predicted risk in
men (χ2 = 14.15, 9df, P = 0.117) and in women (χ2 = 12.36,
9df, P = 0.194) (Figure 2). Additional calibration was made
foreachoftheﬁvestudycohortsat5,10,15,20,and25years,
respectively, for cohorts 2002, 1997, 1992, 1987, and 1982.
The predicted probability of having CHD events at 5, 10, 15,
20, and 25 years was close to those observed at each of the 6
risk categories as shown in supplemental digital Figure S1.
Table 4 shows the net reclassiﬁcations of individuals with
and without events across 10-year risk categories based
on diﬀerent models. The laboratory-based model correctly
reclassiﬁed individuals in both event and non-event groups,
but the overall NRI was signiﬁcant only in men (8.1%,
P = 0.001) not in women (2.9%, P = 0.432) as compared
with the layperson-oriented model. Addition of the systolic
blood pressure to the layperson-oriented model upgraded
both events and non-events, with an overall NRI of 3.8%
(P = 0.053) in men and 7.1% (P = 0.017) in women.
The ROC curves and the NRI for two additional models
that do not contain either the history of diabetes or
hypertension are shown in supplemental digital Figure S2
and Table 2 in Supplementary Material available online at6 International Journal of Vascular Medicine
Table 4: Reclassiﬁcations of individuals based on layperson-oriented model as compared with other two models according to 10-year risk
categories meaningful for intervention.
Layperson oriented
<5% 5–9% 10–19% ≥20% Total NRI (P value)
Men, n (%)
Laboratory based
Non-events 0.011 (0.001)
<5% 10292 (93.3) 718 (6.5) 13 (0.1) 0 (0.0) 11023
5–9% 438 (19.6) 1537 (68.6) 264 (11.8) 0 (0.0) 2239
10–19% 6 (0.7) 333 (37.9) 500 (56.9) 40 (4.6) 879
≥20% 0 (0.0) 9 (4.6) 97 (50.0) 88 (45.4) 194
Total 10736 2597 874 128 14335
Events 0.071 (0.004)
<5% 121 (82.9) 24 (16.4) 1 (0.7) 0 (0.0) 146
5–9% 22 (13.9) 117 (74.1) 19 (12.0) 0 (0.0) 158
10–19% 1 (0.8) 43 (33.9) 74 (58.3) 9 (7.1) 127
≥20% 0 (0.0) 2 (4.1) 19 (38.8) 28 (57.1) 49
Total 144 186 113 37 480
Overall NRI 0.081 (0.001)
Non-laboratory based (Layperson
oriented+systolic blood pressure)
Non-events −0.008 (<0.001)
<5% 10450 (97.2) 301 (2.8) 0 (0.0) 0 (0.0) 10751
5–9% 286 (11.5) 2085 (84.0) 110 (4.4) 0 (0.0) 2481
10–19% 0 (0.0) 211 (22.4) 716 (75.9) 16 (1.7) 943
≥20% 0 (0.0) 0 (0.0) 48 (30.0) 112 (70.0) 160
Total 10736 2597 874 128 14335
Events 0.046 (0.018)
<5% 126 (89.4) 15 (10.6) 0 (0.0) 0 (0.0) 141
5–9% 18 (10.2) 145 (82.4) 13 (7.4) 0 (0.0) 176
10–19% 0 (0.0) 26 (21.7) 90 (75.0) 4 (3.3) 120
≥20% 0 (0.0) 0 (0.0) 10 (23.3) 33 (76.7) 43
Total 144 186 113 37 480
Overall NRI 0.038 (0.053)
Women, n (%)
Laboratory based
Non-events 0.005 (<0.001)
<5% 15420 (98.3) 262 (1.7) 6 (0.0) 0 (0.0) 15688
5–9% 196 (33.3) 331 (56.3) 60 (10.2) 1 (0.2) 588
10–19% 6 (4.3) 44 (31.4) 76 (54.3) 14 (10.0) 140
≥20% 0 (0.0) 1 (3.1) 13 (40.6) 18 (56.3) 32
Total 15622 638 155 33 16448
Events 0.024 (0.516)
<5% 92 (92.9) 7 (7.1) 0 (0.0) 0 (0.0) 99
5–9% 12 (29.3) 21 (51.2) 7 (17.1) 1 (2.4) 41
10–19% 2 (11.1) 4 (22.2) 10 (55.6) 2 (11.1) 18
≥20% 0 (0.0) 0 (0.0) 3 (27.3) 8 (72.7) 11
Total 106 32 20 11 169
Overall NRI 0.029 (0.432)International Journal of Vascular Medicine 7
Table 4: Continued.
Layperson oriented
<5% 5–9% 10–19% ≥20% Total NRI (P value)
Non-laboratory based
(Layperson-oriented+systolic
blood pressure)
Non-events −0.006 (<0.001)
<5% 15404 (99.1) 143 (0.9) 0 (0.0) 0 (0.0) 15547
5–9% 215 (31.1) 449 (64.9) 28 (4.0) 0 (0.0) 692
10–19% 3 (1.8) 46 (27.7) 113 (68.1) 4 (2.4) 166
≥20% 0 (0.0) 0 (0.0) 14 (32.6) 29 (67.4) 43
Total 15622 638 155 33 16448
Events 0.077 (0.009)
<5% 96 (96.0) 4 (4.0) 0 (0.0) 0 (0.0) 100
5–9% 9 (29.0) 22 (71.0) 0 (0.0) 0 (0.0) 31
10–19% 1 (3.8) 6 (23.1) 17 (65.4) 2 (7.7) 26
≥20% 0 (0.0) 0 (0.0) 3 (25.0) 9 (75.0) 12
Total 106 32 20 11 169
Overall NRI 0.071 (0.017)
NRI: net reclassiﬁcation improvement.
doi:11.55/2011/823782. The predictive ability of the models
without either of the two was not impaired substantially in
terms of discrimination and reclassiﬁcation of individuals.
4. Discussion
The performance of the two non-laboratory-based CHD
risk assessment models is good in terms of discrimination
and calibration. Addition of the lipid measurements to the
non-laboratory-based model slightly improved the reclassi-
ﬁcation of individuals in men but not in women, whereas
addition of the systolic blood pressure into the layperson
model improved the reclassiﬁcation of individuals with the
events but overestimated the risk in individuals without
events.
Laboratory tests and blood pressure measurement have
been required in most previous prediction models [5–
12, 16]. A recent study based on the National Health
and Nutrition Examination Survey has, however, challenged
the traditional way of building the models by showing
that laboratory based model including total cholesterol
performed no better than the non-laboratory based model
requiring BMI rather than total cholesterol for predicting
CVD outcomes [14]. Our current study lent further support
to the approach to simplify the risk prediction model.
Moreover, we show that a non-laboratory-based model
not requiring measurement of the systolic blood pressure
performed no worse than that requiring regarding to the
prediction of the 10-year CHD incidence. The advantage
of the simpliﬁed model over the traditional ones is that it
does not require a clinic visit, and therefore, is both time
and cost saving. This is important for CVD prevention using
population approach and in the countries where the medical
care resources are short and blood pressure measurement is
not widely available. In spite of that the guidelines for CVD
prevention have been produced by diﬀerent organizations
and study groups [18–20], most developing countries do
not have a systematic screening program for CVD. A doctor
has no obligation to estimate a patient’s future CVD risk
according to the patient’s current health status. Thus there
is no additional information rather than the complaint
disorders will be discussed and handled during a hospital
visiting. The layperson-oriented model as a supplemental
tool may promote CVD risk screening and prevention
by raising the public awareness of the disease through
population approach, which is beyond the original intention
to apply a CVD risk prediction score in a clinic setting
targeting at high-risk individuals. To include BMI in the
model is particularly important in public health considering
the recent increase in obesity and diabetes worldwide, and
can inform lifestyle changes. “Incapable to walk 500 meters
without rest” appeared to be a strong early sign of the future
CHD in spite of the causes of the inability. Thus, either a
single component of the model or the integrated risk score
estimated based on the model may serve as a trigger leading
to early diagnosis and treatment of the CHD as well as other
comorbidconditions suchashypertension,dyslipidemiaand
hyperglycemia.
It needs, however, to be borne in mind that the
layperson-oriented model derived from the Finnish pop-
ulation has not been externally validated and might need
calibration before it is applied to other populations con-
sidering diﬀerences in CVD risk among countries. In spite
of the diﬀerences in absolute risks, relative risks of certain
risk factors such as smoking are relatively less variable across
c o u n tri e sa n da g egr o u p s[ 21]. A risk score based on estimate
of relative risk has, thus, been suggested but its predictive8 International Journal of Vascular Medicine
property needs to be further investigated against the one
based on estimate of the absolute risk.
Strengths of the current study include its large sample
size, population-based study design, standard survey proto-
cols and questionnaire, reasonable participation rates [15]
and complete followup with ﬁrst ever hard CHD events,
including both fatal and nonfatal events. The Finnish Causes
of Death register and Hospital Discharge register, the source
of the data on CHD events in this study, have high coverage
and diagnostic accuracy as reported previously [22]. The
weakness of the FINRISK study is that the individual’s risk
factors were measured only at the baseline examinations
and the changes in individual’s risk factor levels during the
followup are not known. Considering the decline in CHD
risk and changes in risk factors in the population level in
Finland during the last 35 years [15], the birth cohort-
speciﬁc baseline survival function calculated at the mean
values of covariates of the whole study population of all
cohorts was used to calculate the absolute CHD risk of an
individual person. The risk prediction function developed in
this way has been shown to ﬁt the data of individual cohort
well even though of the cohorts were recruited over a 25-year
period.
In conclusion, the predictive ability of a layperson-
oriented model is similar to the models including laboratory
and systolic blood pressure measurements, but it is simple,
noninvasive, time and cost saving, easy to use and has great
potentialtobeappliedinCVDpreventioncampaignthrough
population approach.
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